Skip to content
GLP Loss
Head to head

He & She MD vs Care Bare Rx

He & She MD strikes through $199 to advertise $99. Care Bare Rx charges the $199 — and neither figure is a quote for one month of one drug.

By Hana BrennanPricing & provider data

Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

He & She MD

Partner

$99/mo

Every headline is an annual prepay: $99 a month for injectable semaglutide means $1,188 charged today, and $159 for tirzepatide means $1,908. The oral runs $199 for six months and renews above that.

  • Every annual total is published in dollars
  • $1,188 divides to an exact $99 month
  • The oral renewal rate is disclosed
  • Fifty states
  • The $99 rate requires $1,188 at enrollment
  • Tirzepatide asks $1,908 before the first dose
  • The oral renews 20% above its opening rate
  • Oral and injectable sit on different terms

Pick it for: Buyers who have already chosen the molecule and the year

Not for: Anyone who needs to pay month by month.

Care Bare Rx

Partner

$199/mo

$199 a month covers a weight-loss line that now names its four products — compounded semaglutide and tirzepatide by injection, oral semaglutide and an oral tirzepatide — without pricing any of them apart. Four dispensing pharmacies are named with addresses and phone numbers.

  • The four products behind the entry price are named
  • Four dispensing pharmacies named with addresses and phone numbers
  • The $199 is stated to include the consultation, shipping and support
  • All fifty states and Puerto Rico
  • No per-molecule price — compounded tirzepatide is unquoted
  • Per-dose figures appear only after an intake that asks for name and email
  • The landing page and the FAQ disagree on whether price varies by dose
  • The branded Ozempic figure differs by page, $749 against $705

Pick it for: Starting this month without committing the year first

Not for: Anyone comparing tirzepatide on price, which cannot be done here before an intake.

Our verdict

At Care Bare Rx that figure is the charge; at He & She MD nothing says what term it would have applied on. What the $99 buys instead is a year decided at enrollment, on a molecule already chosen. Care Bare Rx asks for a month and leaves the molecule open — and its dual-agonist line is prescribed at provider discretion, with no figure of its own, so the buyer most likely to move is the one it prices least.

What actually separates them

He & She MD and Care Bare Rx state different things about published price and where you can use it. Everything else they publish, they publish the same way.

Care Bare Rx costs $100 more than He & She MD — 101% more for the same molecule. Whether that buys anything is what the rest of this page is for.

Over twelve months that is about $1,188 at He & She MD against $2,388 at Care Bare Rx — a difference of $1,200.

 He & She MDCare Bare Rx
Published price$99/mo$199/mo
Where you can use it50 states50 states and Puerto Rico

Before you choose either

Coverage is not the same, and it decides the question outright for anyone living in the gap. He & She MD serves 1 state that Care Bare Rx does not — DC. Care Bare Rx serves 1 that He & She MD does not — LA. Check your own state before you weigh anything else here.

Whether these two publish a milligram dose is not settled in our records for both of them, so treat the two prices as not yet comparable and ask each what dose the monthly figure buys. Set the answers against every published price we hold — a lower monthly price at a smaller dose is not the cheaper option.

Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.

All head-to-head comparisons · The full injections ranking